This isn’t going to be a big pharma data dump… too many non-derm, no relationship field sales reps still trying to find their way… KOL’s respect people who’ve been around in derm. It’s slow - not like PN is super prevalent!
Why this vs Dupi? Half the doses, 75% less med per dose, no pain or conjunctivitis… why start so aggressive when results will be similar with a much less daunting treatment schedule?!
Adult learning principles - see, hear, say, do - and it takes 5-7 interactions for anyone to remember what you said! It’s week 3… calm down, people!